Findings

What do systematic reviews say?

1,822 questions · 1,891 findings · 321 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 279 · 14.8%GRADE not reported 46 · 2.4%Very low 524 · 27.7%Low 571 · 30.2%Moderate 330 · 17.5%High 141 · 7.5%

Anticipated normal responders: higher vs lower dose of FSH

IU vs 225 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure

Anticipated normal responders: higher showed no clear difference in IU vs 225 IU compared with lower dose of FSH (low certainty).

1 finding from 1 review

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro… 2024 · Cochrane Headline outcomes only
OR 0.65 [0.32, 1.32]
1 study · 135 participants
Low

Prevention of eclampsia: higher vs lower IV maintenance regimen

Eclampsia · women with pre‐eclampsia

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 148 participants
Very low

Prevention of eclampsia: higher vs lower IV maintenance regimen

Eclampsia: 2 g per hour IV maintenance versus 1 g per hour IV maintenance · women with pre‐eclampsia

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 62 participants
Very low

Prevention of eclampsia: higher vs lower IV maintenance regimen

Eclampsia: 2 g per hour IV versus weight‐adjusted maintenance dose · women with pre‐eclampsia

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 86 participants
Very low

Prevention of eclampsia: higher vs lower IV maintenance regimen

Severe morbidity · women with pre‐eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prevention of eclampsia: higher vs lower IV maintenance regimen

Side effects · women with pre‐eclampsia

Prevention of eclampsia: higher showed no clear difference in side effects compared with lower IV maintenance regimen (low certainty).

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
RR 0.79 [0.61, 1.01]
1 study · 62 participants
Low

Prevention of eclampsia: higher vs lower IV maintenance regimen

Death of baby (up to discharge) · women with pre‐eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prevention of eclampsia: higher vs lower IV maintenance regimen

Maternal death · women with pre‐eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prevention of eclampsia: higher vs lower IV maintenance regimen

Other neonatal morbidity · women with pre‐eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

Improvement in symptoms · GORD in children over 1 year of age

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 127 participants
Very low

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

Adverse events · GORD in children over 1 year of age

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 127 participants
Very low

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

Endoscopic improvement (dichotomous) · GORD in children over 1 year of age

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 127 participants
Very low

Rabeprazole at higher doses (1 mg/kg) vs rabeprazole at lower doses (0.5 mg/kg)

pH indices ‐ not measured · GORD in children over 1 year of age

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pantoprazole in higher doses (1.2 mg/kg) vs pantoprazole at lower doses (0.3 mg/kg)

Improvement in symptoms · GORD in children over 1 year of age

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Pantoprazole in higher doses (1.2 mg/kg) vs pantoprazole at lower doses (0.3 mg/kg)

Adverse events · GORD in children over 1 year of age

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Pantoprazole in higher doses (1.2 mg/kg) vs pantoprazole at lower doses (0.3 mg/kg)

Improvement in pH indices ‐ not measured · GORD in children over 1 year of age

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pantoprazole in higher doses (1.2 mg/kg) vs pantoprazole at lower doses (0.3 mg/kg)

Endoscopic metrics ‐ not measured · GORD in children over 1 year of age

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐intensity pulsed ultrasound vs control

QoL · acute fractures in adults; included studies assessed effects in complete upper limb fractures (distal radius, clavicle, scaphoid,…

1 finding from 1 review

Ultrasound and shockwave therapy for acute fractures in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 393 participants
Very low

Low‐intensity pulsed ultrasound vs control

Quantitative functional improvement · acute fractures in adults; included studies assessed effects in complete upper limb fractures (distal radius, clavicle, scaphoid,…

The review found no eligible studies for this question.

1 finding from 1 review

Ultrasound and shockwave therapy for acute fractures in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐intensity pulsed ultrasound vs control

Return to previous activities ‐ Resumption of work (days) · acute fractures in adults; included studies assessed effects in complete upper limb fractures (distal radius, clavicle, scaphoid,…

1 finding from 1 review

Ultrasound and shockwave therapy for acute fractures in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 370 participants
Low